GB201810326D0 - Crystalline form of sacubitril, its preparation and use - Google Patents

Crystalline form of sacubitril, its preparation and use

Info

Publication number
GB201810326D0
GB201810326D0 GBGB1810326.7A GB201810326A GB201810326D0 GB 201810326 D0 GB201810326 D0 GB 201810326D0 GB 201810326 A GB201810326 A GB 201810326A GB 201810326 D0 GB201810326 D0 GB 201810326D0
Authority
GB
United Kingdom
Prior art keywords
sacubitril
preparation
crystalline form
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1810326.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson Matthey PLC
Original Assignee
Johnson Matthey PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey PLC filed Critical Johnson Matthey PLC
Priority to GBGB1810326.7A priority Critical patent/GB201810326D0/en
Publication of GB201810326D0 publication Critical patent/GB201810326D0/en
Priority to PCT/GB2019/051696 priority patent/WO2019243799A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
GBGB1810326.7A 2018-06-22 2018-06-22 Crystalline form of sacubitril, its preparation and use Ceased GB201810326D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1810326.7A GB201810326D0 (en) 2018-06-22 2018-06-22 Crystalline form of sacubitril, its preparation and use
PCT/GB2019/051696 WO2019243799A1 (en) 2018-06-22 2019-06-18 Crystalline form of sacubitril, its preparation and use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1810326.7A GB201810326D0 (en) 2018-06-22 2018-06-22 Crystalline form of sacubitril, its preparation and use

Publications (1)

Publication Number Publication Date
GB201810326D0 true GB201810326D0 (en) 2018-08-08

Family

ID=63042574

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1810326.7A Ceased GB201810326D0 (en) 2018-06-22 2018-06-22 Crystalline form of sacubitril, its preparation and use

Country Status (2)

Country Link
GB (1) GB201810326D0 (en)
WO (1) WO2019243799A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217996A (en) * 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
AR057882A1 (en) 2005-11-09 2007-12-26 Novartis Ag DOUBLE ACTION COMPOUNDS OF ANGIOTENSIN RECEPTOR BLOCKERS AND NEUTRAL ENDOPEPTIDASE INHIBITORS
EP3341364B1 (en) * 2015-08-28 2023-12-20 Hetero Labs Ltd. Process for the preparation of a dual-acting angiotensin receptor-neprilysin inhibitor compound
WO2017097275A1 (en) * 2015-12-11 2017-06-15 Zentiva, K.S. Solid forms of (2r,4s)-5-(biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2- -methylpentanoic acid ethyl ester, its salts and a preparation method
WO2017191620A1 (en) * 2016-05-06 2017-11-09 Sun Pharmaceutical Industries Limited A crystalline form of a salt of sacubitril and a process of its preparation
CN109661386A (en) * 2016-09-07 2019-04-19 诺瑞特国际药业股份有限公司 Sha Ku is than bent sodium salt novel crystal forms
KR20180124428A (en) * 2017-05-11 2018-11-21 한미정밀화학주식회사 Crystalline form of sacubitril hemisodium salt, preparation method thereof, and pharmaceutical composition comprising the same
CN108530371B (en) * 2017-12-27 2020-09-01 浙江天宇药业股份有限公司 Sacubitril sodium salt, eutectic compound of Sacubitril free acid and acetic acid, crystal form of Sacubitril free acid and preparation method and application of crystal form

Also Published As

Publication number Publication date
WO2019243799A1 (en) 2019-12-26

Similar Documents

Publication Publication Date Title
IL280963A (en) Anti-gdf15 antibodies, compositions and methods of use
EP3160470A4 (en) Analogs of pridopidine, their preparation and use
IL278829A (en) Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds and immunotherapeutics and methods of use thereof
PL3557998T3 (en) Compouns, compositions and methods of use
IL276814A (en) 5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof
ZA202103498B (en) Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use
EP3530650A4 (en) Crystalline form of (r)-4-hydroxy-2-oxo-1-pyrrolidineacetamide, preparation method therefor and use thereof
SG11202011227VA (en) Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof
GB202101909D0 (en) Novel crystalline form of pyroxa-sulfone, methods for its preparation and use of the same
EP3658278A4 (en) Crystalline metallophosphates, their method of preparation, and use
EP3327012A4 (en) Crystalline forms of bilastine and preparation methods thereof
ZA201906326B (en) Analogs of deutetrabenazine, their preparation and use
SG11202011041YA (en) Combination compositions comprising bisfluoroalkyl-1,4- benzodiazepinone compounds and methods of use thereof
EP4073049A4 (en) Novel crystalline forms of flufenacet, methods for their preparation and use of the same
IL270961A (en) Crystalline form of n-butyldeoxygalactonojirimycin
IL269792B (en) Crystalline forms of (s)-afoxolaner
GB2548342B (en) A novel form of amicarbazone, a process for its preparation and use of the same
IL254597A0 (en) Crystalline form of ahu377, preparation method and use thereof
MX2019010640A (en) Crystalline forms of obeticholic acid.
EP4073050A4 (en) Novel crystalline forms of flufenacet, methods for their preparation and use of the same
GB2559718B (en) Novel crystalline form of tribenuron-methyl, process for preparation and use thereof
EP3328406A4 (en) Mulateiro-derived compositions and use thereof for preventing hair loss and promoting hair growth
EP3658504A4 (en) Crystalline metallophosphates, their method of preparation, and use
GB201810326D0 (en) Crystalline form of sacubitril, its preparation and use
GB2555866B (en) A novel crystalline form of epocholeone, a process for its preparation and use the same

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)